000 | 01068 a2200301 4500 | ||
---|---|---|---|
005 | 20250513030153.0 | ||
264 | 0 | _c19960111 | |
008 | 199601s 0 0 eng d | ||
022 | _a1073-1199 | ||
024 | 7 |
_a10.3109/10731199509117955 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTeicher, B A | |
245 | 0 | 0 |
_aAn overview on oxygen carriers in cancer therapy. _h[electronic resource] |
260 |
_bArtificial cells, blood substitutes, and immobilization biotechnology _c1995 |
||
300 |
_a395-405 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDiffusion |
650 | 0 | 4 | _aFluorocarbons |
650 | 0 | 4 | _aHematocrit |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xblood |
650 | 0 | 4 |
_aOxygen _xblood |
773 | 0 |
_tArtificial cells, blood substitutes, and immobilization biotechnology _gvol. 23 _gno. 3 _gp. 395-405 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10731199509117955 _zAvailable from publisher's website |
999 |
_c7492528 _d7492528 |